A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 4,872 shares of TMDX stock, worth $376,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,872
Previous 22,196 78.05%
Holding current value
$376,118
Previous $3.34 Million 77.15%
% of portfolio
0.0%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$135.68 - $176.11 $2.35 Million - $3.05 Million
-17,324 Reduced 78.05%
4,872 $764,000
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $1.16 Million - $2.4 Million
15,907 Added 252.93%
22,196 $3.34 Million
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $80,567 - $102,250
-1,137 Reduced 15.31%
6,289 $465,000
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $107,097 - $236,348
-2,915 Reduced 28.19%
7,426 $586,000
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $21,655 - $38,908
405 Added 4.08%
10,341 $566,000
Q2 2023

Aug 11, 2023

SELL
$66.23 - $88.73 $37,419 - $50,132
-565 Reduced 5.38%
9,936 $834,000
Q1 2023

May 12, 2023

SELL
$53.63 - $82.33 $1.36 Million - $2.08 Million
-25,316 Reduced 70.68%
10,501 $795,000
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $432,693 - $711,818
-11,072 Reduced 23.61%
35,817 $2.21 Million
Q3 2022

Nov 10, 2022

BUY
$31.56 - $55.75 $822,548 - $1.45 Million
26,063 Added 125.15%
46,889 $1.96 Million
Q2 2022

Aug 11, 2022

BUY
$20.56 - $32.15 $428,182 - $669,555
20,826 New
20,826 $655,000
Q1 2022

May 13, 2022

SELL
$12.58 - $26.94 $328,652 - $703,807
-26,125 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$19.16 - $32.68 $61,331 - $104,608
-3,201 Reduced 10.92%
26,125 $501,000
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $3,136 - $4,175
121 Added 0.41%
29,326 $970,000
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $631,704 - $1.17 Million
29,205 New
29,205 $969,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.46B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.